PT93384A - Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato - Google Patents

Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato

Info

Publication number
PT93384A
PT93384A PT93384A PT9338490A PT93384A PT 93384 A PT93384 A PT 93384A PT 93384 A PT93384 A PT 93384A PT 9338490 A PT9338490 A PT 9338490A PT 93384 A PT93384 A PT 93384A
Authority
PT
Portugal
Prior art keywords
coating material
drug
acrylate
release
meth
Prior art date
Application number
PT93384A
Other languages
English (en)
Other versions
PT93384B (pt
Inventor
Tadayoshi Ohmura
Muneo Fukui
Toshiharu Hosono
Hiroshi Sugiura
Satoru Yoneya
Atsushi Kajiyama
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of PT93384A publication Critical patent/PT93384A/pt
Publication of PT93384B publication Critical patent/PT93384B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
PT93384A 1989-03-10 1990-03-09 Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato PT93384B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5868489 1989-03-10

Publications (2)

Publication Number Publication Date
PT93384A true PT93384A (pt) 1990-11-07
PT93384B PT93384B (pt) 1996-03-29

Family

ID=13091382

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93384A PT93384B (pt) 1989-03-10 1990-03-09 Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato

Country Status (19)

Country Link
US (1) US5028664A (pt)
EP (1) EP0386967B1 (pt)
JP (1) JPH037238A (pt)
KR (1) KR0140985B1 (pt)
CN (1) CN1045524A (pt)
AT (1) ATE124864T1 (pt)
AU (1) AU623233B2 (pt)
CA (1) CA2011919A1 (pt)
DD (2) DD298205A5 (pt)
DE (1) DE69020758T2 (pt)
DK (1) DK0386967T3 (pt)
ES (1) ES2077023T3 (pt)
FI (1) FI97690C (pt)
GR (1) GR3017645T3 (pt)
HU (1) HU204201B (pt)
IE (1) IE68520B1 (pt)
NO (1) NO301578B1 (pt)
NZ (1) NZ232836A (pt)
PT (1) PT93384B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
WO1995005168A1 (en) * 1993-08-19 1995-02-23 Shug Austin L Delayed release carnitine
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
NZ270078A (en) * 1994-12-06 1998-05-27 Bernard Charles Sherman Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
ES2199289T3 (es) * 1995-07-26 2004-02-16 Kyowa Hakko Kogyo Co., Ltd. Dispersion solida de derivados de xantina.
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
CA2320193A1 (en) 1998-02-10 1999-08-19 Welfide Corporation Controlled release preparation
ES2290027T3 (es) * 1999-05-20 2008-02-16 Elan Corporation, Plc Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
WO2001015668A1 (en) * 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release pellet formulation
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
MXPA04004775A (es) * 2001-11-21 2005-02-17 Eisai Co Ltd Composicion de preparacion que contiene un compuesto fisiologicamente activo inestable de acido y un proceso para producirlo.
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
CN100398122C (zh) * 2005-01-28 2008-07-02 北京北大药业有限公司 一种治疗颈、腰椎病中药的肠溶包衣组合物
CA2711475A1 (en) * 2008-01-10 2009-07-16 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
US9011907B2 (en) * 2008-01-10 2015-04-21 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
US8389021B2 (en) * 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
MX2021001276A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos para tratar heridas.
MX2021001272A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos de uso.
WO2022029938A1 (ja) * 2020-08-05 2022-02-10 マルホ株式会社 皮膚用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236914A (en) * 1959-05-12 1966-02-22 Canadian Ind Method for rendering polymers compatible
US3300429A (en) * 1963-06-17 1967-01-24 Rohm & Haas Aqueous polymeric blends containing ureido monomer
US3369009A (en) * 1964-12-10 1968-02-13 Hercules Inc Azidoformate-containing copolymers
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US4065523A (en) * 1975-11-24 1977-12-27 Rohm And Haas Company Process for increasing molecular weight of a polymer
US4082705A (en) * 1976-02-05 1978-04-04 Johnson & Johnson Pressure sensitive adhesive compositions
GB2046275A (en) * 1979-03-27 1980-11-12 American Cyanamid Co Granulation and drying aids for polymeric gels
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
JPS60240747A (ja) * 1984-05-15 1985-11-29 Showa Denko Kk 架橋性組成物及びエステル架橋型重合体
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JP2667162B2 (ja) * 1986-11-04 1997-10-27 日本製紙株式会社 インクジエツト記録用シート
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat

Also Published As

Publication number Publication date
HU901380D0 (en) 1990-05-28
HUT53813A (en) 1990-12-28
NO301578B1 (no) 1997-11-17
EP0386967A3 (en) 1991-04-03
DK0386967T3 (da) 1995-11-20
ES2077023T3 (es) 1995-11-16
NO901116L (no) 1990-09-11
JPH037238A (ja) 1991-01-14
EP0386967A2 (en) 1990-09-12
AU5122790A (en) 1990-09-13
DD292374A5 (de) 1991-08-01
DD298205A5 (de) 1992-02-13
ATE124864T1 (de) 1995-07-15
FI901195A0 (fi) 1990-03-09
FI97690B (fi) 1996-10-31
EP0386967B1 (en) 1995-07-12
IE900862L (en) 1990-09-10
DE69020758T2 (de) 1995-12-07
DE69020758D1 (de) 1995-08-17
KR0140985B1 (ko) 1998-06-01
FI97690C (fi) 1997-02-10
IE68520B1 (en) 1996-06-26
KR900013943A (ko) 1990-10-22
US5028664A (en) 1991-07-02
AU623233B2 (en) 1992-05-07
PT93384B (pt) 1996-03-29
CN1045524A (zh) 1990-09-26
CA2011919A1 (en) 1990-09-10
HU204201B (en) 1991-12-30
GR3017645T3 (en) 1996-01-31
NO901116D0 (no) 1990-03-09
NZ232836A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
PT93384A (pt) Processo para a preparacao de um material de revestimento de controlo da libertacao de droga para formulacoes de accao prolongada contendo copolimeros de (met)acrilato
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
DE59202537D1 (de) Feste pharmazeutische Retardform.
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
ES2094359T3 (es) Formulaciones farmaceuticas de proteinas osteogenicas.
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
AU1351788A (en) Slow-release pharmaceutical agent
KR910011242A (ko) 서방성 약학제제 및 그의 제조방법
DK0519870T3 (da) hidtil ukendt diclofenacpræparat til oral administration
YU184790A (sh) Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen
DE68921500D1 (de) Ultraviolet-stabiles Copolymer, Verfahren zu seiner Herstellung und diese enthaltende Überzugszusammensetzung.
MX9706626A (es) Composiciones farmaceuticas para la liberacion controlada de receptores solubles.
DK0868910T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater som bindemidler til fremstilling af faste farmaceutiske dispergeringsformer
CA2387705A1 (en) Stable pharmaceutical composition for oral use
MY118835A (en) Sustained release compositions and the process for their preparation
CA2176322A1 (en) Color Stable Dental Restorative Materials
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
GB2277872A (en) Pharmaceutical compositions containing nifedipine and process for the preparation thereof
DE69008566D1 (de) Pyridazin-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
RU2000113731A (ru) Пористые частицы гидроксиапатита в качестве носителей для лекарственных веществ
CA2339193A1 (en) Pharmaceutical compositions comprising ibuprofen and domperidone
AU7125991A (en) Novel antiulcer substance
DE69208171D1 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
DK1484033T3 (da) Flydende polymersammensætninger til kontrolleret frigivelse af bioaktive stoffer
AU6210294A (en) Controlled release microcapsules, process for their preparation and pharmaceutical or veterinary compositions containing same

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19951204

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000630